-
IMPLEMENTATION GAPS IN CERVICAL CANCER PREVENTION: PERSPECTIVES OF HEALTHCARE PROFESSIONALS IN NORTH SULAWESI, INDONESIA
Aug 11, 2026, 15:45 PM -
EVALUATING THE HOLISTIC VALUE OF INNOVATIVE THERAPIES VIA THE TREATMENT IMPACT MODEL: A CASE STUDY ON EMICIZUMAB FOR HAEMOPHILIA A IN SINGAPORE
Aug 11, 2026, 15:45 PM -
PROVIDER STRATEGIC RESPONSES TO A BLENDED HOSPITAL PAYMENT REFORM IN CHINA: EVIDENCE ON PATIENT SELECTION, SERVICE ADJUSTMENT, AND PRICE MANIPULATION...
Aug 11, 2026, 15:45 PM -
PRICING STRATEGY SIMULATION UNDER JAPAN’S HEALTH TECHNOLOGY ASSESSMENT SYSTEM: TRADE-OFFS BETWEEN USEFULNESS PREMIUM WITH PRICE MAINTENANCE PROGRAM AND PRICE REDUCTION RISK
Aug 11, 2026, 15:45 PM -
REAL-WORLD COST-UTILITY EVIDENCE SUPPORTING ORAL HEALTH INTEGRATION IN DIABETES CARE IN CHILE
Aug 11, 2026, 15:45 PM -
AI-SUPPORTED PRE-MORTEM ANALYSIS FOR HEOR STRATEGIES: LESSONS FROM PROJECT MANAGEMENT SCIENCE OBJECTIVES
Aug 11, 2026, 15:45 PM -
A PREDICTION MODEL FOR CHRONIC KIDNEY DISEASE PROGRESSION...
Aug 11, 2026, 15:45 PM -
THE ROLE OF CONSUMER COMMENTS IN PBAC RECOMMENDATIONS: INSIGHTS FROM AUSTRALIAN HTA DECISIONS (2020-2025)
Aug 11, 2026, 15:45 PM -
COST-UTILITY OF FIRST-LINE SYSTEMIC THERAPIES FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA IN VIETNAM: A PRELIMINARY ANALYSIS
Aug 11, 2026, 15:45 PM -
COST-EFFECTIVENESS ANALYSIS OF FOLFOXIRI VERSUS FOLFIRI FOR METASTATIC COLORECTAL CANCER
Aug 11, 2026, 15:45 PM -
ASSOCIATION OF SOCIAL ISOLATION, HEALTHY LIFESTYLE, AND ALL-CAUSE MORTALITY AMONG RURAL OLDER ADULTS: JOINT EXPOSURE AND MEDIATION ANALYSES
Aug 11, 2026, 15:45 PM -
INFLUENCE OF ARTIFICIAL INTELLIGENCE ON CLINICAL DECISION-MAKING IN HEALTHCARE: A KAP STUDY AMONG FUTURE PHARMACISTS
Aug 11, 2026, 15:45 PM -
PREDICTORS OF FUNCTIONAL OUTCOME FOLLOWING STROKE A PROSPECTIVE COHORT STUDY FROM NORTHEAST INDIA
Aug 11, 2026, 15:45 PM -
SHARED SAVINGS AND ASSOCIATIONS WITH STROKE OUTCOMES, SPENDING, AND SERVICE UTILIZATION: A SYSTEMATIC REVIEW
Aug 11, 2026, 15:45 PM -
AGE CRITERIA FOR PEDIATRIC RARE DISEASE REIMBURSEMENT UNDER KOREA'S PHARMACOECONOMIC EVALUATION EXEMPTION PATHWAY: A COMPARATIVE ANALYSIS WITH OVERSEAS HTA AGENCIES
Aug 11, 2026, 15:45 PM -
SUPPLY-CHAIN COST IMPLICATIONS OF ULTRA-LOW-TEMPERATURE VERSUS REFRIGERATION STABLE COVID-19 VACCINE FORMULATIONS IN BRAZIL...
Aug 11, 2026, 15:45 PM -
COST-EFFECTIVENESS ANALYSIS OF SOCAZOLIMAB IN ADVANCED SMALL-CELL LUNG CANCER...
Aug 11, 2026, 15:45 PM -
POTENTIAL HEALTHCARE COST SAVINGS FROM OPTIMIZED PRESCRIBING OF ORAL WHO AWARE WATCH ANTIBIOTICS A VIGIACCESS BASED STUDY
Aug 11, 2026, 15:45 PM -
REAL-WORLD HEALTHCARE COSTS BY LINE OF THERAPY IN MULTIPLE MYELOMA: AN INTERNATIONAL SYSTEMATIC LITERATURE REVIEW...
Aug 11, 2026, 15:45 PM -
MODELLING THE MULTIDIMENSIONAL VALUE OF DUPILUMAB FOR SINGAPORE COPD PATIENTS: FROM HEALTHCARE SYSTEMS TO PLANETARY HEALTH...
Aug 11, 2026, 15:45 PM
